Indeed, we have shown that both cognitive deficits and changes in gamma power in a maternal immune activation mouse model of schizophrenia could be reversed by treatment with the selective estrogen receptor modulator (SERM), raloxifene [50]. Here, ESR1 is linked to schizophrenia.